SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on March 6, 2019. The registrant is incorporated in Delaware and maintains its principal executive offices in Los Angeles, California. The report addresses a specific corporate event under Item 8.01 (Other Events).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The material change reported is a personnel appointment. On March 6, 2019, the Company announced the appointment of Dr. Barry Keenan, Ph.D., MBA, PMP, as the new Vice President of Engineering.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, forward-looking outlook statements, risk factor updates, or disclosures of contingencies. The document solely references the press release regarding the executive appointment filed as Exhibit 99.1.
Investor Verification Checklist
- Verify the professional background and qualifications of Dr. Barry Keenan.
- Review the full text of the press release (Exhibit 99.1) for additional context on the engineering leadership strategy.
- Confirm the effective date of the appointment and any associated compensation details not included in this summary.